Vistagen Therapeutics (VTGN) Capital Leases (2011 - 2023)
Vistagen Therapeutics (VTGN) posted Capital Leases of $6000.0 for Q4 2023, down 7.69% sequentially from $6500.0 in Q3 2023, and down 24.05% YoY from $7900.0 in Q4 2022.
Vistagen Therapeutics (VTGN) Capital Leases (2011 - 2023) Analysis & Trends
Vistagen Therapeutics has reported Capital Leases for 9 years, with the latest figure at $6000.0 in Q4 2023.
- Quarterly Capital Leases fell 24.05% year-over-year to $6000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $6000.0 (down 24.05% YoY) and the FY2023 annual result came in at $7400.0, changed N/A from the prior year.
- Capital Leases eased to $6000.0 in Q4 2023 per VTGN's latest filing, from $6500.0 in the prior quarter.
- Over five years, Capital Leases peaked at $8700.0 in Q2 2022 and troughed at $300.0 in Q4 2020.
- A 4-year average of $5260.0 and a median of $6000.0 in 2023 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2020 and 2023: Capital Leases slumped 92.31% in 2020, then decreased 19.54% in 2023.
- Over 4 years, Capital Leases stood at $3900.0 in 2019, then plunged by 92.31% to $300.0 in 2020, then soared by 2533.33% to $7900.0 in 2022, then slipped by 24.05% to $6000.0 in 2023.
- According to Business Quant data, Capital Leases over the past three periods registered $6000.0, $6500.0, and $7000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Vistagen Therapeutics | 10.41 Mn | 10.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,500.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,400.00 |
| Dec 31, 2022 | 7,900.00 |
| Sep 30, 2022 | 8,300.00 |
| Jun 30, 2022 | 8,700.00 |
| Dec 31, 2020 | 300.00 |
| Sep 30, 2020 | 1,300.00 |
| Jun 30, 2020 | 2,100.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 3,900.00 |
| Sep 30, 2019 | 4,700.00 |
| Jun 30, 2019 | 5,500.00 |
| Mar 31, 2019 | 6,300.00 |
| Dec 31, 2018 | 7,100.00 |
| Sep 30, 2018 | 7,900.00 |
| Jun 30, 2018 | 8,600.00 |
| Mar 31, 2018 | 9,300.00 |
| Dec 31, 2017 | 10,000.00 |